SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 7.2% Stake in Alignment Healthcare Inc.

FMR LLC and its affiliates, along with Abigail P. Johnson, have disclosed a beneficial ownership of 7.2% in Alignment Healthcare Inc., totaling over 13.9 million common shares.

Summary

• FMR LLC, a Delaware-organized entity, and Abigail P. Johnson, a U.S. citizen, have jointly filed an Amendment No. 3 to Schedule 13G regarding their beneficial ownership in ALIGNMENT HEALTHCARE INC.
• As of March 31, 2025, FMR LLC and Abigail P. Johnson collectively beneficially own 13,957,406.73 shares of ALIGNMENT HEALTHCARE INC's common stock.
• This aggregate amount represents 7.2% of the outstanding common stock of ALIGNMENT HEALTHCARE INC.
• FMR LLC holds sole voting power over 13,956,487.73 shares and sole dispositive power over 13,957,406.73 shares.
• Abigail P. Johnson holds sole dispositive power over 13,957,406.73 shares, with no sole or shared voting power directly attributed to her in this filing.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as entities beneficially owning shares, with Fidelity Management & Research Company LLC owning 5% or greater.
• The Johnson family, including Abigail P. Johnson, are the predominant owners of FMR LLC's Series B voting common shares, representing 49% of the voting power, and have a voting agreement that may deem them a controlling group with respect to FMR LLC.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a reputable institutional investor like FMR LLC is generally viewed positively, indicating confidence in the company. While it's a passive investment, it adds a layer of institutional backing.

Positives

• The disclosure of a significant stake by a major institutional investor like FMR LLC can signal confidence in ALIGNMENT HEALTHCARE INC's long-term prospects.
• The acquisition of shares in the ordinary course of business suggests a strategic investment rather than an activist intent, which can be viewed positively by current management.

Risks

• The concentration of a significant ownership percentage (7.2%) by a single institutional investor and its affiliates could potentially lead to increased influence over company decisions, although the filing states the shares are not held for control purposes.
• Future changes in the investor's position (e.g., significant selling) could exert downward pressure on the stock price.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from ALIGNMENT HEALTHCARE INC.

Industry Context

This filing indicates a significant institutional investment in ALIGNMENT HEALTHCARE INC, a company operating in the healthcare sector. Such investments by large asset managers like FMR LLC are common across various industries, including healthcare, as they seek to gain exposure to specific market segments or companies they believe have strong growth potential. The healthcare industry, particularly segments related to managed care and senior health, often attracts substantial institutional capital due to demographic trends and ongoing innovation.

Stakeholder Impact

• **Shareholders:** Existing shareholders may view the significant institutional investment as a positive signal, potentially leading to increased investor confidence and stability in the stock.
• **Company Management:** The presence of a large, passive institutional investor like FMR LLC typically provides a stable shareholder base, allowing management to focus on long-term strategic goals without immediate pressure for control changes.

Key Dates

Keywords

ALIGNMENT HEALTHCARE INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare, SEC Filing, Stake Disclosure